Renal fibrosis progression following partial unilateral ureteral obstruction: mechanisms and therapeutic insights
Authors:
Open Access
- 17 April 2025
- journal article
- review article
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-6
Abstract
Ureteral obstruction, a common clinical condition, is associated with various renal disorders affecting all age groups and can lead to permanent renal damage. In Partial unilateral ureteral obstruction (PUUO), increased ureteral pressure, and decreased glomerular filtration rate (GFR) in the affected kidney cause cellular and molecular abnormalities, which ultimately lead to renal fibrosis if untreated. While removing the obstruction (RUUO) is essential to prevent long-term damage, additional therapeutic approaches may be necessary to fully restore kidney function. The PUUO model is used to induce renal fibrosis, primarily characterized by tubular injury resulting from obstructed urine flow. PUUO in rodents can simulate human chronic obstructive nephropathy at an accelerated rate. Although alleviating the obstruction can reduce immediate symptoms, it is often insufficient to reverse established fibrosis, emphasizing the need for adjunctive therapies. The renal response to RUUO depends on factors like the obstruction’s duration and severity, as well as the contralateral kidney's functional state.Keywords
Funding Information
- Mansoura University
This publication has 31 references indexed in Scilit:
- Synergy of zinc oxide nanoparticles to losartan attenuates kidney injury induced by unilateral ureteral obstruction through modulation of the TNF-α/IL6 and BAX/BCL2 signaling pathwaysInternational Urology and Nephrology, 2025
- Small extracellular vesicles-shuttled miR-23a-3p from mesenchymal stem cells alleviate renal fibrosis and inflammation by inhibiting KLF3/STAT3 axis in diabetic kidney diseaseInternational Immunopharmacology, 2024
- Ureteral Obstruction Promotes Ureteral Inflammation and FibrosisEuropean Urology Focus, 2022
- Protective role of zinc oxide nanoparticles in kidney injury induced by cisplatin in ratsLife Sciences, 2020
- The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosisPharmacological Research, 2018
- Telbivudine attenuates UUO-induced renal fibrosis via TGF-β/Smad and NF-κB signalingInternational Immunopharmacology, 2018
- Thymoquinone ameliorates renal damage in unilateral ureteral obstruction in ratsPharmacological Reports, 2017
- β-Aminoisobutyric acid ameliorates the renal fibrosis in mouse obstructed kidneys via inhibition of renal fibroblast activation and fibrosisJournal of Pharmacological Sciences, 2017
- Metformin prevents renal interstitial fibrosis in mice with unilateral ureteral obstructionMolecular and Cellular Endocrinology, 2015
- Partial unilateral ureteral obstruction in ratsNeurourology and Urodynamics, 2002